{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T18:34:42Z","timestamp":1771007682212,"version":"3.50.1"},"reference-count":68,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2011,10,28]],"date-time":"2011-10-28T00:00:00Z","timestamp":1319760000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0027067","type":"journal-article","created":{"date-parts":[[2011,10,28]],"date-time":"2011-10-28T17:02:02Z","timestamp":1319821322000},"page":"e27067","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":23,"title":["Erythropoietin Enhances Nerve Repair in Anti-Ganglioside Antibody-Mediated Models of Immune Neuropathy"],"prefix":"10.1371","volume":"6","author":[{"given":"Gang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helmar C.","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nataliia","family":"Bogdanova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiangyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazim A.","family":"Sheikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2011,10,28]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1093\/brain\/awf272","article-title":"Peripheral neuropathies and anti-glycolipid antibodies.","volume":"125","author":"HJ Willison","year":"2002","journal-title":"Brain"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1529-8027.2011.00323.x","article-title":"CIDP-the relevance of recent advances in Schwann cell\/axonal neurobiology.","volume":"16","author":"JD Pollard","year":"2011","journal-title":"J Peripher Nerv Syst"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0140-6736(05)67665-9","article-title":"Guillain-Barre syndrome.","volume":"366","author":"RA Hughes","year":"2005","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0022-510X(92)90217-9","article-title":"Antibodies to acidic glycolipids in Guillain-Barr\u00e9 syndrome and chronic inflammatory demyelinating polyneuropathy.","volume":"107","author":"AA Ilyas","year":"1992","journal-title":"J Neurol Sci"},{"key":"ref5","first-page":"111","article-title":"Antibodies to gangliosides in Guillain-Barre syndrome: Specificity and relationship to clinical features.","volume":"86","author":"NA Gregson","year":"1993","journal-title":"Quart J Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0022-510X(93)90048-4","article-title":"Serum and CSF anti-GM1 antibodies in patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyneuropathy.","volume":"114","author":"IL Simone","year":"1993","journal-title":"J Neurol Sci"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/ana.410440210","article-title":"IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barre syndrome.","volume":"44","author":"S Kuwabara","year":"1998","journal-title":"Ann Neurol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1212\/WNL.51.6.1656","article-title":"Two patterns of clinical recovery in Guillain-Barre syndrome with IgG anti-GM1 antibody.","volume":"51","author":"S Kuwabara","year":"1998","journal-title":"Neurology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/ana.410400209","article-title":"<italic>Campylobacter jejuni<\/italic> intections and anti-GM1 antibodies in Guillain-Barr\u00e9 syndrome.","volume":"40","author":"BC Jacobs","year":"1996","journal-title":"Ann Neurol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/mus.880160610","article-title":"Association of IgG anti-GD1a antibody with severe Guillain-Barre syndrome.","volume":"16","author":"N Yuki","year":"1993","journal-title":"Muscle Nerve"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0022-510X(99)00173-2","article-title":"Clinical presentation and outcome of Guillain-Barre and related syndromes in relation to anti-ganglioside antibodies.","volume":"168","author":"M Carpo","year":"1999","journal-title":"J Neurol Sci"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0022-510X(01)00580-9","article-title":"Temporal profile of anti-ganglioside antibodies and their relation to clinical parameters and treatment in Guillain-Barre syndrome.","volume":"190","author":"R Press","year":"2001","journal-title":"J Neurol Sci"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1212\/WNL.56.6.758","article-title":"Preceding infections, immune factors, and outcome in Guillain-Barre syndrome.","volume":"56","author":"RD Hadden","year":"2001","journal-title":"Neurology"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1212\/01.WNL.0000061615.77865.83","article-title":"Anti-GM1 antibody IgG subclass: a clinical recovery predictor in Guillain-Barre syndrome.","volume":"60","author":"M Koga","year":"2003","journal-title":"Neurology"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1523\/JNEUROSCI.4017-06.2007","article-title":"Passive immunization with anti-ganglioside antibodies directly inhibits axon regeneration in an animal model.","volume":"27","author":"HC Lehmann","year":"2007","journal-title":"J Neurosci"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"9533","DOI":"10.1523\/JNEUROSCI.2281-10.2010","article-title":"Passive Transfer of IgG Anti-GM1 Antibodies Impairs Peripheral Nerve Repair.","volume":"30","author":"PH Lopez","year":"2010","journal-title":"J Neurosci"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1523\/JNEUROSCI.3829-10.2011","article-title":"Anti-Ganglioside Antibody-Mediated Activation of RhoA Induces Inhibition of Neurite Outgrowth.","volume":"31","author":"G Zhang","year":"2011","journal-title":"J Neurosci"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"142","DOI":"10.2169\/internalmedicine.42.142","article-title":"Pleiotropic functions of erythropoietin.","volume":"42","author":"R Sasaki","year":"2003","journal-title":"Internal Medicine"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"10526","DOI":"10.1073\/pnas.97.19.10526","article-title":"Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury.","volume":"97","author":"ML Brines","year":"2000","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"6741","DOI":"10.1073\/pnas.1031753100","article-title":"Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo.","volume":"100","author":"S Erbayraktar","year":"2003","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nrn1687","article-title":"Emerging biological roles for erythropoietin in the nervous system.","volume":"6","author":"M Brines","year":"2005","journal-title":"Nature Reviews Neuroscience"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/BF03402029","article-title":"Erythropoietin therapy for acute stroke is both safe and beneficial.","volume":"8","author":"H Ehrenreich","year":"2002","journal-title":"Molecular Medicine"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1093\/brain\/awm203","article-title":"Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis.","volume":"130","author":"H Ehrenreich","year":"2007","journal-title":"Brain"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.mcn.2005.04.009","article-title":"Erythropoietin promotes regeneration of adult CNS neurons via Jak2\/Stat3 and PI3K\/Akt pathway activation.","volume":"29","author":"A Kretz","year":"2005","journal-title":"Molecular and Cellular Neuroscience"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1073\/pnas.0307823100","article-title":"Erythropoietin both protects from and reverses experimental diabetic neuropathy.","volume":"101","author":"R Bianchi","year":"2004","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref26","first-page":"7","article-title":"EPO-analogue CEPO not only protects but even reverses peripheral nerve abnormalities in streptozotocin-diabetic rats.","volume":"10","author":"R Bianchi","year":"2005","journal-title":"Journal of the Peripheral Nervous System"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.neuroscience.2008.03.052","article-title":"Local erythropoietin signaling enhances regeneration in peripheral axons.","volume":"154","author":"C Toth","year":"2008","journal-title":"Neuroscience"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/1531-8249(199902)45:2<168::AID-ANA6>3.0.CO;2-6","article-title":"Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barre syndrome.","volume":"45","author":"TW Ho","year":"1999","journal-title":"Ann Neurol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/ana.20285","article-title":"A novel endogenous erythropoietin mediated pathway prevents axonal degeneration.","volume":"56","author":"SC Keswani","year":"2004","journal-title":"Ann Neurol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1096\/fj.00-0857fje","article-title":"Erythropoietin and erythropoietin receptors in the peripheral nervous system: changes after nerve injury.","volume":"15","author":"WM Campana","year":"2001","journal-title":"FASEB J"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00429-005-0019-3","article-title":"Expression patterns of erythropoietin and its receptor in the developing spinal cord and dorsal root ganglia.","volume":"210","author":"W Knabe","year":"2005","journal-title":"Anat Embryol (Berl)"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/jnr.21832","article-title":"Neuroprotective effects of erythropoietin posttreatment against kainate-induced excitotoxicity in mixed spinal cultures.","volume":"87","author":"JY Yoo","year":"2009","journal-title":"J Neurosci Res"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.nurt.2008.10.041","article-title":"Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system.","volume":"6","author":"AL Siren","year":"2009","journal-title":"Neurotherapeutics"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1093\/brain\/awq101","article-title":"Neuroprotective properties of a novel, non-haematopoietic agonist of the erythropoietin receptor.","volume":"133","author":"S Pankratova","year":"2010","journal-title":"Brain"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0959-4388(00)00180-X","article-title":"Rho GTPases in growth cone guidance.","volume":"11","author":"BJ Dickson","year":"2001","journal-title":"Curr Opin Neurobiol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/nature01148","article-title":"Rho GTPases in cell biology.","volume":"420","author":"S Etienne-Manneville","year":"2002","journal-title":"Nature"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/35044547","article-title":"Rho GTPases in neuronal morphogenesis.","volume":"1","author":"L Luo","year":"2000","journal-title":"Nat Rev Neurosci"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1146\/annurev.cellbio.18.031802.150501","article-title":"Actin cytoskeleton regulation in neuronal morphogenesis and structural plasticity.","volume":"18","author":"L Luo","year":"2002","journal-title":"Annu Rev Cell Dev Biol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1146\/annurev.neuro.26.010302.081139","article-title":"Signaling at the growth cone: ligand-receptor complexes and the control of axon growth and guidance.","volume":"26","author":"AB Huber","year":"2003","journal-title":"Annu Rev Neurosci"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.expneurol.2008.04.033","article-title":"Magnetic resonance imaging of mouse skeletal muscle to measure denervation atrophy.","volume":"212","author":"J Zhang","year":"2008","journal-title":"Exp Neurol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0165-5728(99)00195-2","article-title":"Pathogenesis of Guillain-Barre syndrome.","volume":"100","author":"RA Hughes","year":"1999","journal-title":"J Neuroimmunol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00005792-196905000-00001","article-title":"The inflammatory lesion in idiopathic polyneuritis.","volume":"48","author":"AK Asbury","year":"1969","journal-title":"Medicine"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/brain\/107.1.219","article-title":"Conduction block and denervation in Guillain-Barre polyneuropathy.","volume":"107","author":"WF Brown","year":"1984","journal-title":"Brain"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/brain\/109.6.1115","article-title":"An acute axonal form of Guillain-Barre polyneuropathy.","volume":"109","author":"TE Feasby","year":"1986","journal-title":"Brain"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/00005072-195607000-00005","article-title":"A comparative study of experimental allergic neuritis in the rabbit, guinea pig, and mouse.","volume":"15","author":"BH Waksman","year":"1956","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S1357-4310(99)01639-1","article-title":"Animal models for autoimmune demyelinating disorders of the nervous system.","volume":"6","author":"R Gold","year":"2000","journal-title":"Mol Med Today"},{"key":"ref47","first-page":"47","article-title":"Immunology of the Schwann cell.","volume":"5","author":"PJ Armati","year":"1996","journal-title":"Baillieres Clin Neurol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/mus.10432","article-title":"Neurophysiological changes in demyelinating and axonal forms of acute experimental autoimmune neuritis in the Lewis rat.","volume":"28","author":"JM Taylor","year":"2003","journal-title":"Muscle Nerve"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0960-8966(01)00302-9","article-title":"Immune mechanisms in acquired demyelinating neuropathies: lessons from animal models.","volume":"12","author":"M Maurer","year":"2002","journal-title":"Neuromuscul Disord"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"4044","DOI":"10.1073\/pnas.051606598","article-title":"Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress.","volume":"98","author":"AL Siren","year":"2001","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S1043-2760(98)00101-5","article-title":"The Erythropoietin Receptor: Structure, Activation and Intracellular Signal Transduction.","volume":"10","author":"SN Constantinescu","year":"1999","journal-title":"Trends Endocrinol Metab"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0168-9525(00)89000-9","article-title":"Jaks and Stats in signaling by the cytokine receptor superfamily.","volume":"11","author":"JN Ihle","year":"1995","journal-title":"Trends Genet"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/cdd.2008.1","article-title":"Essential role for Stat5 in the neurotrophic but not in the neuroprotective effect of erythropoietin.","volume":"15","author":"N Byts","year":"2008","journal-title":"Cell Death Differ"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.neulet.2004.08.080","article-title":"Erythropoietin is neuroprotective in models of HIV sensory neuropathy.","volume":"371","author":"SC Keswani","year":"2004","journal-title":"Neurosci Lett"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1126\/science.1098313","article-title":"Derivatives of erythropoietin that are tissue protective but not erythropoietic.","volume":"305","author":"M Leist","year":"2004","journal-title":"Science"},{"key":"ref56","article-title":"Guillain-Barre Syndrome.","author":"AH Ropper","year":"1991"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/jnnp.64.1.74","article-title":"Epidemiological study of Guillain-Barre syndrome in south east England.","volume":"64","author":"JH Rees","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1056\/NEJM198701083160203","article-title":"Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial.","volume":"316","author":"JW Eschbach","year":"1987","journal-title":"N Engl J Med"},{"key":"ref59","first-page":"e38","article-title":"Does erythropoietin have a dark side? Epo signaling and cancer cells.","volume":"2007","author":"AJ Sytkowski","year":"2007"},{"key":"ref60","first-page":"697","article-title":"Monoclonal antibodies raised against Guillain-Barre syndrome- associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations [published erratum appears in J Clin Invest 1999 Dec;104(12):1771].","volume":"104","author":"CS Goodyear","year":"1999","journal-title":"J Clin Invest"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"11404","DOI":"10.1073\/pnas.0402391101","article-title":"Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome.","volume":"101","author":"N Yuki","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/ana.20173","article-title":"An anti-ganglioside antibody-secreting hybridoma induces neuropathy in mice.","volume":"56","author":"KA Sheikh","year":"2004","journal-title":"Ann Neurol"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1046\/j.1471-4159.2000.0750404.x","article-title":"High-affinity anti-ganglioside IgG antibodies raised in complex ganglioside knockout mice: reexamination of GD1a immunolocalization.","volume":"75","author":"MP Lunn","year":"2000","journal-title":"J Neurochem"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1093\/brain\/awh127","article-title":"Anti-ganglioside antibody-mediated neuronal cytotoxicity and its protection by intravenous immunoglobulin: implications for immune neuropathies.","volume":"127","author":"G Zhang","year":"2004","journal-title":"Brain"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1083\/jcb.105.2.1023","article-title":"Differentiation of axon-related Schwann cells in vitro. I. Ascorbic acid regulates basal lamina assembly and myelin formation.","volume":"105","author":"CF Eldridge","year":"1987","journal-title":"J Cell Biol"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.nbd.2004.03.001","article-title":"IGF-I prevents glutamate-induced motor neuron programmed cell death.","volume":"16","author":"AM Vincent","year":"2004","journal-title":"Neurobiol Dis"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1006\/bbrc.2001.5085","article-title":"Low doses of EPO activate MAP kinases but not JAK2-STAT5 in rat vascular smooth muscle cells.","volume":"284","author":"F Ammarguellat","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"7532","DOI":"10.1073\/pnas.96.13.7532","article-title":"Mice lacking complex gangliosides develop Wallerian degeneration and myelination defects.","volume":"96","author":"KA Sheikh","year":"1999","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0027067","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,18]],"date-time":"2019-06-18T15:42:30Z","timestamp":1560872550000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0027067"}},"subtitle":[],"editor":[{"given":"Pablo","family":"Villoslada","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2011,10,28]]},"references-count":68,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2011,10,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0027067","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,28]]}}}